Table 3.
CTCAE graded treatment toxicity.
| Patient | Dermatitis (acute) | Skin changes (late) | Breast infection (acute) | Breast infection (late) | Seroma (acute) | Seroma (late) | Fibrosis (acute) | Fibrosis (late) | Breast pain (acute) | Breast pain (late) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| 4 | 0 | 0 | 0 | 2 | 1 | 2 | 0 | 0 | 0 | 0 |
| 5 | 1 | 0 | 2 | 0 | 2 | 0 | 0 | 1 | 0 | 0 |
| 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 7 | 1 | 0 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 0 |
| 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 9 | 0 | 1 | 0 | 0 | 1 | 2 | 0 | 1 | 0 | 0 |
| 10 | 0 | 1 | 0 | 3 | 1 | 2 | 0 | 1 | 0 | 0 |
| 11 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Total | 25% | 25% | 17% | 25% | 42% | 42% | 0 | 42% | 8% | 8% |
All toxicity graded per the NCI CTCAE version 4.02; acute defined as within 3 months from intraoperative radiotherapy treatment.